Article
BRAF mutations in papillary thyroid carcinoma.
Endocrine regulations - 1 Dec 2006
Wojciechowska Katarzyna, Lewinski Andrzej
Abstract excerpt
Papillary thyroid carcinoma (PTC) is the most frequent malignant neoplasm of the thyroid originating from the thyroid follicular cell (TFC). Although the formation of PTC is believed to result from rearrangements of RET or TRK oncogenes or MET point mutations, these structural aberrations or point mutations do not correlate with the clinicopathological features of PTC and do not seem to be a useful prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
